Avadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Avadel Pharmaceuticals plc (Nasdaq: AVDL) will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on September 14 at 11:30 a.m. E.T. The discussion will focus on the company's innovative approaches to medicine, notably their lead drug candidate, LUMRYZ™, which is designed for the treatment of cataplexy and excessive daytime sleepiness in adults with narcolepsy. Investors can access a live webcast and archived recording on the Investor Relations website.

DUBLIN, Ireland, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Wednesday, September 14 at 11:30 a.m. E.T.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, LUMRYZ™, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Gabriella Greig
Real Chemistry
ggreig@realchemistry.com 
(203) 249-2688

FAQ

When is Avadel Pharmaceuticals' fireside chat at the H.C. Wainwright Global Investment Conference?

Avadel Pharmaceuticals' fireside chat is scheduled for September 14 at 11:30 a.m. E.T.

Where can I watch the live webcast of Avadel Pharmaceuticals' fireside chat?

The live webcast of Avadel Pharmaceuticals' fireside chat can be watched on their Investor Relations website.

What is the focus of Avadel Pharmaceuticals' presentation at the conference?

The presentation will highlight Avadel's innovative medicine approaches, especially their lead drug candidate, LUMRYZ™.

What is LUMRYZ™ developed by Avadel Pharmaceuticals?

LUMRYZ™ is an investigational formulation of sodium oxybate for treating cataplexy and excessive daytime sleepiness in adults with narcolepsy.

How long will the webcast of Avadel Pharmaceuticals' conference be available?

The archived recording of the webcast will be available for 90 days following the conference.